Myelin-Associated Glycoprotein, antagonists & inhibitors
- Name
- Myelin-Associated Glycoprotein, antagonists & inhibitors
- Accession Number
- DBCAT004623
- Description
Not Available
- Drugs
Drug Drug Description Refanezumab Refanezumab is under investigation in clinical trial NCT00833989 (Safety Escalating Repeat IV, in Stroke Patients). - Drugs & Drug Targets
Drug Target Type